医学
甲硝唑
阿米巴病
替硝唑
腹泻
帕罗莫霉素
无症状的
痢疾
疾病
硝唑烷
儿科
内科学
重症监护医学
外科
免疫学
抗生素
病理
氨基糖苷
微生物学
生物
作者
Shipra Gupta,Layne Smith,Adriana Diakiw
标识
DOI:10.1016/j.pcl.2021.08.003
摘要
Although rare in the developed world, amebiasis continues to be a leading cause of diarrhea and illness in developing nations with crowding, poor sanitation, and lack of clean water supply. Recent immigrants or travelers returning from endemic regions after a prolonged stay are at high risk of developing amebiasis. A high index of suspicion for amebiasis should be maintained for other high-risk groups like men having sex with men, people with AIDS/HIV, immunocompromised hosts, residents of mental health facility or group homes. Clinical presentation of intestinal amebiasis varies from diarrhea to colitis and dysentery. Amebic liver abscess (ALA) is the most common form of extraintestinal amebiasis. Various diagnostic tools are available and when amebiasis is suspected, a combination of stool tests and serology should be sent to maximize the yield of testing. Treatment with an amebicidal drug such as metronidazole/tinidazole and a luminal cysticidal agent such as paromomycin for clinical disease is indicated. However, for asymptomatic disease treatment with a luminal cysticidal agent to decrease chances of invasive disease and transmission is recommended.
科研通智能强力驱动
Strongly Powered by AbleSci AI